Literature DB >> 21103873

Endovascular treatment of phlegmasia cerulea dolens with impending venous gangrene: manual aspiration thrombectomy as the first-line thrombus removal method.

Levent Oguzkurt1, Ugur Ozkan, Orhan S Demirturk, Serkan Gur.   

Abstract

PURPOSE: Our purpose was to report the outcome of endovascular treatment with manual aspiration thrombectomy as the first-line thromboablative method for phlegmasia cerulea dolens.
METHODS: Between October 2006 and May 2010, seven consecutive patients (5 women, 2 men; age range, 31-80 years) with the diagnosis of phlegmasia cerulea dolens secondary to acute iliofemoral deep venous thrombosis had endovascular treatment with manual aspiration thrombectomy. Catheter-directed thrombolysis and stent placement were used as adjunctive procedures. Phlegmasia was left-sided in five and right-sided in two patients.
RESULTS: All patients had associated great saphenous vein thrombosis in addition to iliofemoral deep vein thrombosis (DVT). Aspiration thrombectomy completely removed the thrombus from the popliteal vein to the inferior vena cava (IVC) in all cases. Three patients with May-Thurner syndrome had stent placement in the left common iliac vein. Two patients had early recurrences. Repeated aspiration thrombectomy was unsuccessful in one patient. There were no complications related to the procedure. One patient who had been successfully treated died of sepsis and another patient who had unsuccessful repeated interventions had below-the-knee amputation. Overall, the clinical success and survival rates of patients in this study were 86%. On follow-up, three patients with successful treatment were asymptomatic with no deep venous insufficiency. One of these patients died during the 4-month follow-up period. Two patients had mild ankle swelling with deep venous insufficiency.
CONCLUSIONS: Manual aspiration thrombectomy with adjunctive use of catheter-directed thrombolysis and stent placement is an effective endovascular treatment method with high clinical success and survival rates for phlegmasia cerulean dolens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103873     DOI: 10.1007/s00270-010-0042-5

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Phlegmasia Cerulea Dolens, a Deadly Complication of Deep Vein Thrombosis: Case Report and Review of Literature.

Authors:  Ban Ibrahim; Raviprasad Kattimani
Journal:  Cureus       Date:  2021-11-26

Review 2.  Catheter-Based Therapies and Other Management Strategies for Deep Vein Thrombosis and Post-Thrombotic Syndrome.

Authors:  Siddhant Thukral; Suresh Vedantham
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

3.  Phlegmasia Alba Dolens Complicating Rhabdomyolysis.

Authors:  Leonardo P Suciadi; Aloysius N Aristo
Journal:  Cureus       Date:  2021-03-24

4.  Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.

Authors:  Neema Jamshidi; Weiyi Tan; Dingle Foote; Leigh Reardon; Gentian Lluri; Jamil Aboulhosn; John Moriarty; Jeannette Lin
Journal:  BMC Cardiovasc Disord       Date:  2021-12-09       Impact factor: 2.298

5.  Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ?

Authors:  Oussama Anane; Abdellah Rezziki; Adnane Benzirar; Omar El Mahi
Journal:  Ann Med Surg (Lond)       Date:  2021-07-03

6.  Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review.

Authors:  Pascale Notten; Hugo Ten Cate; Arina J Ten Cate-Hoek
Journal:  J Thromb Haemost       Date:  2021-01-05       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.